Figure 3.
Figure 3. Cumulative incidence of competing risks after treatment in 533 patients with advanced-stage Hodgkin lymphoma.

Cumulative incidence of competing risks after treatment in 533 patients with advanced-stage Hodgkin lymphoma.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal